Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
add, adenocarcinoma, admission, adulterated, agent, Agouron, allergy, Almita, ambiguity, apoptotic, asthma, attestation, Austen, autism, automation, Avram, Baltimore, Barnard, began, bibliographic, BioCore, Bioengineering, biomarker, biopsy, border, Boston, BPCA, branded, breakdown, BTG, California, carcinoma, Celator, chromosome, Cincinnati, clear, CML, codified, College, consignment, Cornell, COSO, count, CR, CRi, cyber, cytotoxic, database, Daunorubicin, Debasish, defeat, derecognition, die, Diego, dietary, disband, Dohme, donor, DSHEA, Eastern, ECL, editor, Eduardo, EHA, enasidenib, entry, Enzymedica, epilepsy, Estybon, exact, fight, Flagged, flagging, FVOCI, Gersten, gilteritinib, GlaxoSmithKline, Globulin, GlutenEase, Goldenberg, GQLife, graft, grantee, grossed, grown, guadecitabine, Halle, Harmonisation, Harold, herbal, Hershko, HLA, homeopathic, honeymoon, hope, HSPC, hybrid, hypomethylating, IIb, ImmusanT, incomplete, infiltration, ingestion, insight, insulin, Irwin, Jevtana, Jolla, Jorge, keytruda, kg, La, lab, Latin, leadership, leakage, Lidak, liposomal, Lytix, MAA, malware, Mankind, MDACC, Mekinist, melanoma, Merril, metastatic, Methylprednisolone, methylprednisone, Metvixia, misbranded, Modernization, module, moiety, mouse, MSD, NEC, Network, neuroblastoma, newly, Nirvan, nivolumab, notion, novo, Odomzo, Opdivo, outlicensed, Palestinian, pancreatic, pembrolizumab, Pertinax, plerixafor, PUMA, PVTF, Qinprezo, Rappaport, raw, reactivity, RedHill, refractory, remission, rescinded, resubmit, Revlimid, Rose, Rotterdam, Roychowdhury, Salk, San, Scholar, SE, sector, Sharp, shortly, SOHO, stretched, stronger, Tarceva, theft, Tolerase, transparent, triple, Turkey, twelve, Tykerb, unauthorized, undergone, underwent, upstream, USD, vaccine, Velcade, voluntarily, Wartner, Western, Zeda, Zolinza
Removed:
Abbot, Abbott, abdominal, abnormal, accumulate, ACE, acetylcholinesterase, adalimumab, AEs, Affordability, agonist, agonistic, Aliza, allotted, alteration, AMD, antipsychotic, arrhythmia, artery, assigned, atherosclerotic, attachment, attend, autoimmunity, back, Beer, bench, billion, BioFund, Biogen, BL, bloating, blockage, British, Budesonide, calcium, cardiovascular, certolizumab, Chart, CHF, Childhood, chronically, Cimzia, clastogenic, clean, closed, cognitive, compounded, congestive, consented, constrain, coronary, Cosmo, Crohn, Cyclophosphamide, damaged, datamonitor, Dean, decreasing, delegate, deployed, designing, dexamethasone, dilation, discontinuation, discovering, discussing, DNA, dog, dual, ejection, elapse, elevated, elevation, encouraging, endocrinology, entail, enzyme, Eshkol, Ester, exacerbated, excise, exert, expend, Ferring, FISEB, fludarabine, Fred, functioning, Galilee, gel, Geneva, Gianni, gold, golimumab, GP, gradual, Gromo, harmful, Hartum, headed, healing, hemorrhaging, histological, Humira, Hutchinson, Ichilov, incidence, inflammation, inflation, infliximab, initiating, insufficiently, integrin, interim, intervention, invited, ISMB, Itamar, Jak, Korea, Ladkani, launched, liquid, LV, match, Memorandum, men, mesalazine, Mestinon, Metvix, mg, MGFA, mimic, Mitsubishi, MMX, moderate, moderately, Mor, morbidity, mortality, Moshe, muscle, myasthenia, Naparstek, NasVax, natalizumab, naturally, neurological, nitrogen, nucleic, occlusion, optionee, participated, pathological, payroll, Phillip, photodynamic, pig, preventive, propriety, protective, publication, pumped, QMG, Questionnaire, Rambam, reacquire, reacquisition, reader, rebate, receivable, Reconciliation, reconsider, reimbursing, remained, Remicade, reorganize, representation, restricting, Restructuring, retired, Rothschild, routine, SA, SAB, Sackler, SAE, scaffold, scar, Schneider, score, Seattle, sequence, Serono, Shaare, Shalit, shape, Sheva, Simponi, Soroka, Sourasky, South, sponsored, STEMI, stent, steroidal, structural, subsidize, superior, suppressor, survive, Tanabe, tofacitinib, Transduction, transform, transformation, Tysabri, UCB, UK, ulcerative, unchanged, underwater, uptake, VAT, ventricle, winter, women, Xeljanz, Yaakov, Zealand, Zedek
Filing tables
Filing exhibits
BLRX similar filings
Filing view
External links
Exhibit 15.5
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-176419, 333-183976, 333-201326 and 333-208865) and on Form F-3 (Nos. 333-179792, 333-196390 and 333-205700) of BIOLINERX LTD. (the “Company”), of our report dated March 8, 2016, relating to the financial statements of the Company, which appears in this Form 20-F.
Tel-Aviv, Israel March 10, 2016 | /s/ Kesselman & Kesselman Certified Public Accountants (Isr.) A member firm of PricewaterhouseCoopers International Limited |
Kesselman & Kesselman, Trade Tower, 25 Hamered Street, Tel-Aviv 68125, Israel, P.O Box 452 Tel-Aviv 61003 Telephone: +972 -3- 7954555, Fax:+972 -3- 7954556, www.pwc.co.il |
Kesselman & Kesselman is a member firm of PricewaterhouseCoopers International Limited, each member firm of which is a separate legal entity |